HIV infection and bone disease: implications for an aging population

Sex Health. 2011 Dec;8(4):493-501. doi: 10.1071/SH11014.

Abstract

Now more than ever, the management of age-related problems, from cardiovascular morbidity to bone pathology, is increasingly relevant for HIV physicians. Low bone mineral density (BMD) and fractures are more common in HIV-infected patients. Although a multifactorial aetiology underlies this condition, increasing evidence suggests a role for antiretroviral therapy in low BMD, especially upon initiation. This review will detail the epidemiology, pathogenesis, diagnosis and management of osteoporosis and low BMD in HIV-infected patients, with particular emphasis on aging.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aging*
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Bone Density / drug effects
  • Bone Density Conservation Agents / therapeutic use
  • Bone Diseases / drug therapy*
  • Bone Diseases / epidemiology*
  • Bone Diseases / virology
  • Comorbidity
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology*
  • Humans
  • Life Expectancy
  • Risk Factors

Substances

  • Anti-HIV Agents
  • Bone Density Conservation Agents